ADC Therapeutics SA Contributions To Plan By Plan Participants Net Defined Benefit Liability Asset
ADC Therapeutics SA (ADCT) reported Contributions To Plan By Plan Participants Net Defined Benefit Liability Asset of $0 for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-15.
Discontinued › Notes
ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset · last filed 2023-03-15
| Period end | Contributions To Plan By Plan Participants Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2022-12-31 | $0.00 20-F · filed 2023-03-15 |
| 2021-12-31 | $0.00 20-F · filed 2023-03-15 |
| 2020-12-31 | $0.00 20-F · filed 2022-03-17 |
| 2019-12-31 | $0.00 20-F · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |